← FDA Drug Approvals (Drugs@FDA)

BELRAPZO

NDA · New Drug Application · Sponsor: EAGLE PHARMS · Approved 2018-05-15

Drug application

FDA Application #

NDA205580

Application type

New Drug Application

Brand name

BELRAPZO

Generic name

BENDAMUSTINE HYDROCHLORIDE

Active ingredients

BENDAMUSTINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

EAGLE PHARMS

Manufacturer

Eagle Pharmaceuticals, Inc

First approval

2018-05-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown